Journal of Commercial Biotechnology

Editorial: Yin, yang and the biopharmaceutical industry
pp. 283-285(3)
Author: Miller, Henry I

Opinion piece: Biotechnology's growth-innovation paradox and the new model for success
pp. 286-288(3)
Author: Baker, Ann

Life after Enron and ImClone: Special concerns for the biotechnology company
pp. 289-296(8)
Author: Aronson, Neil H

The key to successful collaborations: Rigorous and independent due diligence
pp. 297-304(8)
Authors: Rhodes, Ian; Nelson, Craig; Berman, Gregory

Dominating global intellectual property: Overview of patentability in the USA, Europe and Japan
pp. 305-331(27)
Authors: Kowalski, Thomas J; Maschio, Antonio; Megerditchian, Samuel H

Patent issues and future trends in drug development
pp. 332-338(7)
Authors: Kermani, Faiz; Bonacossa, Pietro

Strategies for building a global healthcare biotechnology company
pp. 339-344(6)
Author: Geraghty, James A

Regulatory Submissions Trends Survey 2002
pp. 345-357(13)
Author: Semple, Ellen

Marketspace: Trends in biotherapeutics
pp. 358-363(6)
Author: Pavlou, Alex K

Legal and regulatory update: Voluntary withdrawal of marketing authorisations and consequences for parallel importers
pp. 364-371(8)
Author: Wilkinson, John

EU Financial accounts reports
pp. 372-374(3)
Author: Citron, David